Danaparoid
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Danaparoid and local guidelines before prescribing.
Heparinoid
Mechanism
Heparinoid anticoagulant.
Uses
Heparin-induced thrombocytopenia.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Bleeding.
Interactions
Anticoagulants.
Contraindications and cautions
Active bleeding
Monitoring
Anti-Xa
Pregnancy and breastfeeding
Use if needed
Renal and hepatic impairment
Avoid in severe renal impairment
Overdose and reversal
Supportive
Special advice
Anti-Xa monitoring.
More from the textbook: uses, cautions and other points
- Stop all heparin (including flushes) and start a non-heparin anticoagulant ( argatroban , fondaparinux, danaparoid, or a DOAC per specialist); don't give platelets; avoid warfarin until platelets recover.
Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing - Assess with the 4Ts score; test for HIT antibodies; stop all heparin and start a non-heparin anticoagulant (argatroban, danaparoid, fondaparinux); don't give platelets.
Cardiology: Anatomy Physiology and Pharmacology - Stop all heparin (including line flushes and heparin-coated catheters); start a non-heparin anticoagulant (argatroban, danaparoid, fondaparinux or a DOAC - specialist advice).
Haematology: Anatomy Physiology and Pharmacology - Stop all heparin ; start argatroban (or danaparoid, fondaparinux, a DOAC).
Haematology: Emergencies - Start a non-heparin anticoagulant at treatment dose (even without thrombosis) - argatroban , danaparoid, fondaparinux, or a DOAC.
Haematology: Haemostasis and Thrombosis
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Emergencies (1 mention)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)